{"id":768918,"date":"2023-07-11T10:49:47","date_gmt":"2023-07-11T14:49:47","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/strata-announces-jcad-publication-photopneumatic-technology-for-the-treatment-of-mild-to-moderate-acne-vulgaris\/"},"modified":"2023-07-11T10:49:47","modified_gmt":"2023-07-11T14:49:47","slug":"strata-announces-jcad-publication-photopneumatic-technology-for-the-treatment-of-mild-to-moderate-acne-vulgaris","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/strata-announces-jcad-publication-photopneumatic-technology-for-the-treatment-of-mild-to-moderate-acne-vulgaris\/","title":{"rendered":"STRATA Announces JCAD Publication: Photopneumatic Technology for the Treatment of Mild-to-Moderate Acne Vulgaris"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">HORSHAM, Pa., July  11, 2023  (GLOBE NEWSWIRE) &#8212; STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced the <em>Journal of Clinical and Aesthetic Dermatology<\/em> (JCAD) <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=OeLsSPX8zgA4I0EM24Fjg7Lx_uVCiKgjXRoMlW5IXNhuXoJMYIhQNnMUc62fHZIYM_DKYj1qXxvaXKT2GWmiG-LhvW1IhTg1sxnjB3Grk19mhORZBLeGtkaYappyuz16w_HefT20SY2dBkX-g4Ljlw==\" rel=\"nofollow noopener\" target=\"_blank\"><u>published<\/u><\/a> a review and an expert perspectives article in the June 2023 Supplemental edition titled, \u201cPhotopneumatic Technology for the Treatment of Mild-to-Moderate Acne Vulgaris.\u201d<\/p>\n<p>In the review, Gilly Munavalli, MD, highlighted the TheraClear<sup>\u00ae<\/sup>X system, which included its mechanism of action, key features of the device, and the clinical outcomes experienced. Dr. Munavalli also recounted anecdotal results of using the device in the treatment of acne.<\/p>\n<p>\u201cTheraClearX is a tool we often utilize in the clinic to treat mild-to-moderate acne,\u201d stated Dr. Gilly Munavalli, Medical Director and Founder of Dermatology, Laser, &amp; Vein Specialists of the Carolinas in Charlotte, North Carolina. \u201cWith patients experiencing little-to-no downtime and visible reductions in redness early on in their treatment, we believe the TheraClearX system is an effective, non-pharmaceutical acne treatment.\u201d<\/p>\n<p>The clinical perspective article expands on the expert perspectives derived from a virtual roundtable conducted in February 2023 which featured Ashish Bhatia, MD, FAAD, Cheryl M. Burgess, MD, FAAD, Gilly S. Munavalli, MD, MHS, FACMS, and Jason L. Smith, MD. The roundtable participants discussed the TheraClearX system, its mechanism of action, the customizable device settings, treatment protocols, and practice integration. Key takeaways from the expert perspectives article include:<\/p>\n<ul type=\"disc\">\n<li>It is safe and efficacious, with visible improvement of acne as soon as the second treatment.<\/li>\n<li>Additional benefits include visible improvement of pore size, erythema, and skin texture.<\/li>\n<li>Settings can be customized to treat all Fitzpatrick skin types.<\/li>\n<li>Treatment sessions are quick and comfortable, with no downtime resulting in compliant and satisfied patients.<\/li>\n<li>Ideal for a new acne patient wanting to expedite their acne clearance and\/or an existing patient wanting to enhance their current acne regimen.<\/li>\n<\/ul>\n<p align=\"justify\">\u201cThe TheraClearX review and expert perspectives article highlights the device\u2019s safety and efficacy and emphasizes the visible improvement patients often experience soon after beginning treatment,\u201d stated Bob Moccia, Chief Executive Officer of STRATA Skin Sciences. \u201cImportantly, the information presented in the JCAD supplement expands on how the TheraClearX device fits into the acne treatment landscape and how the device can be seamlessly integrated into a physician\u2019s practice.\u201d<\/p>\n<p>\n        <strong>About STRATA Skin Sciences, Inc.<br \/><\/strong>STRATA Skin Sciences is a medical technology company dedicated to developing, commercializing and marketing innovative products for the in-office treatment of various dermatologic conditions such as psoriasis, vitiligo, and acne. Its products include the XTRAC<sup>\u00ae <\/sup>excimer laser, VTRAC<sup>\u00ae<\/sup> lamp systems, and the TheraClear<sup>\u00ae<\/sup>X Acne Therapy System.<\/p>\n<p align=\"justify\">STRATA is proud to offer these exciting technologies in the U.S. through its unique Partnership Program. STRATA\u2019s popular partnership approach includes a fee per treatment cost structure versus an equipment purchase, installation and use of the device, on-site training for practice personnel, service and maintenance of the equipment, dedicated account and customer service associates, and co-op advertising support to help raise awareness and promote the program within the practice.<\/p>\n<p align=\"justify\">\n        <strong>Safe Harbor<br \/><\/strong>This press release includes &#8220;forward-looking statements&#8221; within the meaning of the Securities Litigation Reform Act of 1995. These statements include but are not limited to the Company\u2019s plans, objectives, expectations and intentions and may contain words such as \u201cwill,\u201d \u201cmay,\u201d \u201cseeks,\u201d and \u201cexpects,\u201d that suggest future events or trends. These statements, the Company\u2019s ability to launch and sell an acne treatment device and to integrate that device into its product offerings, the Company\u2019s ability to develop, launch and sell products recently acquired or to be developed in the future, the Company\u2019s ability to develop social media marketing campaigns, direct to dermatologist marketing campaigns, and the Company\u2019s ability to build a leading franchise in dermatology and aesthetics, are based on the Company\u2019s current expectations and are inherently subject to significant uncertainties and changes in circumstances. Actual results may differ materially from the Company\u2019s expectations due to financial, economic, business, competitive, market, regulatory, adverse market conditions labor supply shortages, or supply chain interruptions resulting from the coronavirus, fiscal, and political factors, responses, or conditions affecting the Company, the medical device industry and our customers and patients in general, as well as more specific risks and uncertainties set forth in the Company\u2019s SEC reports on Forms 10-Q and 10-K. Given such uncertainties, any or all these forward-looking statements may prove to be incorrect or unreliable. The statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on its website or otherwise. The Company does not undertake any obligation to update or revise these statements to reflect events or circumstances occurring after the date of this press release. The Company urges investors to carefully review its SEC disclosures available at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=amScDE6PLNUMyg6b-OYaY37IZlLbS5SZ18Gl0e6mts13NuMySy2ziHsctYbNOj06lCJas0y_76S_gxHxB02X0Hp8fzOc7J9MeNBsY_iBlzT_7bK_Ih5N0WY7VyLgSlcY25uuHTk7Q7IKinj5NVMqgV_PnoPJKz8TYBmd7Sr-g8K8PL6DFjCIVBi87F1RemwZG8kgoNjes5o5LTkA1sQgUrnIOrIbr97crVprpMt9V6g=\" rel=\"nofollow noopener\" target=\"_blank\">www.sec.gov<\/a> and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=amScDE6PLNUMyg6b-OYaY4_wXV1QiZsTDvnW2FoELo1X3edxEQqx95vRLBD54vkHOSO3l4QS64zFORgK8LUVFAZeFD8UockmAZycXPqaz0UaZ7UTtUFVij3-P6HxdJEZ4TkwzuZCRxndwfsQm6nS2g3E_jYC8PsRb2R3wKWRFmOCD43U02tQdocJHN-qMKHdx29yA9OTjzsy73Xu6HvQ7SwmulcKGHfXHAfhcOvA0-GeeRhtD7awCXyPndSRLrdSbqPd6yE_C43uG_T0X4KtnSW8AKbRMcf259GwZ24a264=\" rel=\"nofollow noopener\" target=\"_blank\">www.strataskinsciences.com<\/a>.<\/p>\n<p>\n        <strong>Investor Contact:<\/strong><br \/>\n        <br \/>Rich Cockrell<br \/>CG Capital<br \/>Phone: +1 (404) 736-3838<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=a4CJtuql2wLPiNzMHbzepUUZprdEOZO5XbOZKRu7IxzoCNwGJ32mifawufN4pXsTgmKI7Z472KWW_A7uwEfPn3y6jXTVodIeWAyKEoDvBYJhvCRruEm5iCDtitddQ3nQ3oQU2fTr9c86_Sj8SN1poHbV9IPlc7QWD30ghkYqoy5YI1yrRCtk4yrYiOvJVEq407So8iiwWF6iNFHcuUFtkuAZyFkmHA4ceSllcXK1Y0Y=\" rel=\"nofollow noopener\" target=\"_blank\">sskn@cg.capital<\/a><\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg3MjA2NCM1Njg1Mzc5IzIwMTA1MTQ=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/YmZhN2Y0M2UtZjBhMS00MjM0LWE3NzYtOTE2NDFlZDE2ZTlhLTEwMjIwODc=\/tiny\/STRATA-Skin-Sciences-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>HORSHAM, Pa., July 11, 2023 (GLOBE NEWSWIRE) &#8212; STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced the Journal of Clinical and Aesthetic Dermatology (JCAD) published a review and an expert perspectives article in the June 2023 Supplemental edition titled, \u201cPhotopneumatic Technology for the Treatment of Mild-to-Moderate Acne Vulgaris.\u201d In the review, Gilly Munavalli, MD, highlighted the TheraClear\u00aeX system, which included its mechanism of action, key features of the device, and the clinical outcomes experienced. Dr. Munavalli also recounted anecdotal results of using the device in the treatment of acne. \u201cTheraClearX is a tool we often utilize in the clinic to treat mild-to-moderate &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/strata-announces-jcad-publication-photopneumatic-technology-for-the-treatment-of-mild-to-moderate-acne-vulgaris\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;STRATA Announces JCAD Publication: Photopneumatic Technology for the Treatment of Mild-to-Moderate Acne Vulgaris&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-768918","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>STRATA Announces JCAD Publication: Photopneumatic Technology for the Treatment of Mild-to-Moderate Acne Vulgaris - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/strata-announces-jcad-publication-photopneumatic-technology-for-the-treatment-of-mild-to-moderate-acne-vulgaris\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"STRATA Announces JCAD Publication: Photopneumatic Technology for the Treatment of Mild-to-Moderate Acne Vulgaris - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"HORSHAM, Pa., July 11, 2023 (GLOBE NEWSWIRE) &#8212; STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced the Journal of Clinical and Aesthetic Dermatology (JCAD) published a review and an expert perspectives article in the June 2023 Supplemental edition titled, \u201cPhotopneumatic Technology for the Treatment of Mild-to-Moderate Acne Vulgaris.\u201d In the review, Gilly Munavalli, MD, highlighted the TheraClear\u00aeX system, which included its mechanism of action, key features of the device, and the clinical outcomes experienced. Dr. Munavalli also recounted anecdotal results of using the device in the treatment of acne. \u201cTheraClearX is a tool we often utilize in the clinic to treat mild-to-moderate &hellip; Continue reading &quot;STRATA Announces JCAD Publication: Photopneumatic Technology for the Treatment of Mild-to-Moderate Acne Vulgaris&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/strata-announces-jcad-publication-photopneumatic-technology-for-the-treatment-of-mild-to-moderate-acne-vulgaris\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-07-11T14:49:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg3MjA2NCM1Njg1Mzc5IzIwMTA1MTQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/strata-announces-jcad-publication-photopneumatic-technology-for-the-treatment-of-mild-to-moderate-acne-vulgaris\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/strata-announces-jcad-publication-photopneumatic-technology-for-the-treatment-of-mild-to-moderate-acne-vulgaris\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"STRATA Announces JCAD Publication: Photopneumatic Technology for the Treatment of Mild-to-Moderate Acne Vulgaris\",\"datePublished\":\"2023-07-11T14:49:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/strata-announces-jcad-publication-photopneumatic-technology-for-the-treatment-of-mild-to-moderate-acne-vulgaris\\\/\"},\"wordCount\":829,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/strata-announces-jcad-publication-photopneumatic-technology-for-the-treatment-of-mild-to-moderate-acne-vulgaris\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg3MjA2NCM1Njg1Mzc5IzIwMTA1MTQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/strata-announces-jcad-publication-photopneumatic-technology-for-the-treatment-of-mild-to-moderate-acne-vulgaris\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/strata-announces-jcad-publication-photopneumatic-technology-for-the-treatment-of-mild-to-moderate-acne-vulgaris\\\/\",\"name\":\"STRATA Announces JCAD Publication: Photopneumatic Technology for the Treatment of Mild-to-Moderate Acne Vulgaris - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/strata-announces-jcad-publication-photopneumatic-technology-for-the-treatment-of-mild-to-moderate-acne-vulgaris\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/strata-announces-jcad-publication-photopneumatic-technology-for-the-treatment-of-mild-to-moderate-acne-vulgaris\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg3MjA2NCM1Njg1Mzc5IzIwMTA1MTQ=\",\"datePublished\":\"2023-07-11T14:49:47+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/strata-announces-jcad-publication-photopneumatic-technology-for-the-treatment-of-mild-to-moderate-acne-vulgaris\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/strata-announces-jcad-publication-photopneumatic-technology-for-the-treatment-of-mild-to-moderate-acne-vulgaris\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/strata-announces-jcad-publication-photopneumatic-technology-for-the-treatment-of-mild-to-moderate-acne-vulgaris\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg3MjA2NCM1Njg1Mzc5IzIwMTA1MTQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg3MjA2NCM1Njg1Mzc5IzIwMTA1MTQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/strata-announces-jcad-publication-photopneumatic-technology-for-the-treatment-of-mild-to-moderate-acne-vulgaris\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"STRATA Announces JCAD Publication: Photopneumatic Technology for the Treatment of Mild-to-Moderate Acne Vulgaris\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"STRATA Announces JCAD Publication: Photopneumatic Technology for the Treatment of Mild-to-Moderate Acne Vulgaris - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/strata-announces-jcad-publication-photopneumatic-technology-for-the-treatment-of-mild-to-moderate-acne-vulgaris\/","og_locale":"en_US","og_type":"article","og_title":"STRATA Announces JCAD Publication: Photopneumatic Technology for the Treatment of Mild-to-Moderate Acne Vulgaris - Market Newsdesk","og_description":"HORSHAM, Pa., July 11, 2023 (GLOBE NEWSWIRE) &#8212; STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced the Journal of Clinical and Aesthetic Dermatology (JCAD) published a review and an expert perspectives article in the June 2023 Supplemental edition titled, \u201cPhotopneumatic Technology for the Treatment of Mild-to-Moderate Acne Vulgaris.\u201d In the review, Gilly Munavalli, MD, highlighted the TheraClear\u00aeX system, which included its mechanism of action, key features of the device, and the clinical outcomes experienced. Dr. Munavalli also recounted anecdotal results of using the device in the treatment of acne. \u201cTheraClearX is a tool we often utilize in the clinic to treat mild-to-moderate &hellip; Continue reading \"STRATA Announces JCAD Publication: Photopneumatic Technology for the Treatment of Mild-to-Moderate Acne Vulgaris\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/strata-announces-jcad-publication-photopneumatic-technology-for-the-treatment-of-mild-to-moderate-acne-vulgaris\/","og_site_name":"Market Newsdesk","article_published_time":"2023-07-11T14:49:47+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg3MjA2NCM1Njg1Mzc5IzIwMTA1MTQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/strata-announces-jcad-publication-photopneumatic-technology-for-the-treatment-of-mild-to-moderate-acne-vulgaris\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/strata-announces-jcad-publication-photopneumatic-technology-for-the-treatment-of-mild-to-moderate-acne-vulgaris\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"STRATA Announces JCAD Publication: Photopneumatic Technology for the Treatment of Mild-to-Moderate Acne Vulgaris","datePublished":"2023-07-11T14:49:47+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/strata-announces-jcad-publication-photopneumatic-technology-for-the-treatment-of-mild-to-moderate-acne-vulgaris\/"},"wordCount":829,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/strata-announces-jcad-publication-photopneumatic-technology-for-the-treatment-of-mild-to-moderate-acne-vulgaris\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg3MjA2NCM1Njg1Mzc5IzIwMTA1MTQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/strata-announces-jcad-publication-photopneumatic-technology-for-the-treatment-of-mild-to-moderate-acne-vulgaris\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/strata-announces-jcad-publication-photopneumatic-technology-for-the-treatment-of-mild-to-moderate-acne-vulgaris\/","name":"STRATA Announces JCAD Publication: Photopneumatic Technology for the Treatment of Mild-to-Moderate Acne Vulgaris - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/strata-announces-jcad-publication-photopneumatic-technology-for-the-treatment-of-mild-to-moderate-acne-vulgaris\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/strata-announces-jcad-publication-photopneumatic-technology-for-the-treatment-of-mild-to-moderate-acne-vulgaris\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg3MjA2NCM1Njg1Mzc5IzIwMTA1MTQ=","datePublished":"2023-07-11T14:49:47+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/strata-announces-jcad-publication-photopneumatic-technology-for-the-treatment-of-mild-to-moderate-acne-vulgaris\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/strata-announces-jcad-publication-photopneumatic-technology-for-the-treatment-of-mild-to-moderate-acne-vulgaris\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/strata-announces-jcad-publication-photopneumatic-technology-for-the-treatment-of-mild-to-moderate-acne-vulgaris\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg3MjA2NCM1Njg1Mzc5IzIwMTA1MTQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg3MjA2NCM1Njg1Mzc5IzIwMTA1MTQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/strata-announces-jcad-publication-photopneumatic-technology-for-the-treatment-of-mild-to-moderate-acne-vulgaris\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"STRATA Announces JCAD Publication: Photopneumatic Technology for the Treatment of Mild-to-Moderate Acne Vulgaris"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/768918","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=768918"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/768918\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=768918"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=768918"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=768918"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}